Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Valeri

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Cancer Epidemiology|August 19, 2014
An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancerBríd M Ryan, Roger K Wolff, Nicola Valeri, et al.
JAMA Oncology|February 28, 2017
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) TrialElizabeth C Smyth, Andrew Wotherspoon, Clare Peckitt, et al.
Annals of Hematology|November 29, 2019
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trialAndrea Kühnl, Clare Peckitt, Bijal Patel, et al.
Frontiers in Oncology|December 14, 2023
MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patientsHazel Lote, Florentia Mousoullou, George Vlachogiannis, et al.
American Journal of Clinical Pathology|April 11, 2017
Early miR-223 Upregulation in Gastroesophageal CarcinogenesisMatteo Fassan, Deborah Saraggi, Laura Balsamo, et al.
Cancers|September 3, 2020
A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 PandemicAlberto Zaniboni, Michele Ghidini, Francesco Grossi, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 20, 2021
DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastasesMihaela Rata, Khurum Khan, David J Collins, et al.
Haematologica|August 5, 2018
Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphomaAfua A Mensah, Luciano Cascione, Eugenio Gaudio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2012
Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samplesGerard J Nuovo, Michela Garofalo, Nicola Valeri, et al.
Pathology, Research and Practice|March 6, 2020
Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesisMatteo Fassan, Stefano Realdon, Luciano Cascione, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Cancer Epidemiology|August 19, 2014
An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancerBríd M Ryan, Roger K Wolff, Nicola Valeri, et al.
JAMA Oncology|February 28, 2017
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) TrialElizabeth C Smyth, Andrew Wotherspoon, Clare Peckitt, et al.
Annals of Hematology|November 29, 2019
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trialAndrea Kühnl, Clare Peckitt, Bijal Patel, et al.
Frontiers in Oncology|December 14, 2023
MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patientsHazel Lote, Florentia Mousoullou, George Vlachogiannis, et al.
American Journal of Clinical Pathology|April 11, 2017
Early miR-223 Upregulation in Gastroesophageal CarcinogenesisMatteo Fassan, Deborah Saraggi, Laura Balsamo, et al.
Cancers|September 3, 2020
A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 PandemicAlberto Zaniboni, Michele Ghidini, Francesco Grossi, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 20, 2021
DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastasesMihaela Rata, Khurum Khan, David J Collins, et al.
Haematologica|August 5, 2018
Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphomaAfua A Mensah, Luciano Cascione, Eugenio Gaudio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2012
Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samplesGerard J Nuovo, Michela Garofalo, Nicola Valeri, et al.
Pathology, Research and Practice|March 6, 2020
Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesisMatteo Fassan, Stefano Realdon, Luciano Cascione, et al.
Pageof 10